Identification of SARS-CoV-2 surface therapeutic targets and drugs using molecular modeling methods for inhibition of the virus entry

Although COVID-19 emerged as a major concern to public health around the world, no licensed medication has been found as of yet to efficiently stop the virus spread and treat the infection. The SARS-CoV-2 entry into the host cell is driven by the direct interaction of the S1 domain with the ACE-2 re...

Descripción completa

Detalles Bibliográficos
Autores principales: Farhadian, Sadegh, Heidari-Soureshjani, Ehsan, Hashemi-Shahraki, Fatemeh, Hasanpour-Dehkordi, Ali, Uversky, Vladimir N., Shirani, Majid, Shareghi, Behzad, Sadeghi, Mehraban, Pirali, Esmaeil, Hadi-Alijanvand, Saeid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797986/
https://www.ncbi.nlm.nih.gov/pubmed/35125515
http://dx.doi.org/10.1016/j.molstruc.2022.132488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797986/
https://www.ncbi.nlm.nih.gov/pubmed/35125515
http://dx.doi.org/10.1016/j.molstruc.2022.132488

Ejemplares similares